subscribeSubscribe
Sage `highly encouraged` by Zurzuvae launch with Biogen

Sage `highly encouraged` by Zurzuvae launch with Biogen
FIERCE PHARMA
14 Feb 2024
Share Share
ZURZUVAE a Landmark Oral Treatment for PPD, is Now Available in the U.S.

ZURZUVAE a Landmark Oral Treatment for PPD, is Now Available in the U.S.
GLOBENEWSWIRE
14 Dec 2023
Share Share
Sage, Biogen call an audible on pricing strategy for Zurzuvae

Sage, Biogen call an audible on pricing strategy for Zurzuvae
Kevin Dunleavy FIERCE PHARMA
07 Nov 2023
Share Share
FDA documents hint ‘uphill battle’ for broad approval of Sage’s depression drug

FDA documents hint ‘uphill battle’ for broad approval of Sage’s depression drug
Jacob Bell BIOPHARMADIVE
02 Sep 2023
Share Share
Sage shrinks workforce by 40% in light of major depression drug rejection

Sage shrinks workforce by 40% in light of major depression drug rejection
Kyle LaHucik ENDPTS
01 Sep 2023
Share Share
Sage considers cuts after FDA’s split decision on depression drug

Sage considers cuts after FDA’s split decision on depression drug
BIOPHARMADIVE
08 Aug 2023
Share Share
US FDA approves Biogen-Sage Therapeutics pill for postpartum depression

US FDA approves Biogen-Sage Therapeutics pill for postpartum depression
REUTERS
05 Aug 2023
Share Share
Novel investigational postpartum depression pill showed improvement in depressive symptoms

Novel investigational postpartum depression pill showed improvement in depressive symptoms
BUSINESSWIRE
26 Jul 2023
Share Share
FDA says no adcomm planned for Biogen, Sage`s depression drug

FDA says no adcomm planned for Biogen, Sage`s depression drug
ENDPTS
09 Mar 2023
Share Share
Sage Therapeutics & Biogen Share Update on FDA Advisory Committee for Zuranolone

Sage Therapeutics & Biogen Share Update on FDA Advisory Committee for Zuranolone
BUSINESSWIRE
08 Mar 2023
Share Share